# Effects of Letrozole During the Luteal Phase After Controlled Ovarian Stimulation in Oocyte Donors.

> **NCT06244745** · PHASE3 · RECRUITING · sponsor: **IVI Madrid** · enrollment: 152 (estimated)

## Conditions studied

- Luteinised Follicular Cyst

## Interventions

- **DRUG:** Administration of letrozole

## Key facts

- **NCT ID:** NCT06244745
- **Lead sponsor:** IVI Madrid
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-15
- **Primary completion:** 2025-05-01
- **Final completion:** 2025-05-31
- **Target enrollment:** 152 (ESTIMATED)
- **Last updated:** 2025-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06244745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06244745, "Effects of Letrozole During the Luteal Phase After Controlled Ovarian Stimulation in Oocyte Donors.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06244745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*